Selected article for: "GBS Guillain Barrà syndrome and Guillain Barrà syndrome"
Author: Diez-Porras, Laura; Vergés, Enric; Gil, Francisco; Vidal, Mª José; Massons, Joan; Arboix, AdriÃ
Title: Guillain-Barré-Strohl syndrome and COVID-19: case report and literature review
  • Cord-id: o92jodfs
  • Document date: 2020_8_12
    • ID: o92jodfs
    Snippet: In recent months, the new beta-coronavirus has caused a pandemic with symptoms affecting mainly the respiratory system. It is established that the virus may play a neurotropic role and in recent months several cases of Guillain-Barré-Strohl syndrome (GBS) have been reported in patients infected with COVID-19. We report the case of a 54-year old patient with acute demyelinating polyneuropathy during infection by SARS-CoV-2 who progressed clinically to require assisted ventilation. After several
    Document: In recent months, the new beta-coronavirus has caused a pandemic with symptoms affecting mainly the respiratory system. It is established that the virus may play a neurotropic role and in recent months several cases of Guillain-Barré-Strohl syndrome (GBS) have been reported in patients infected with COVID-19. We report the case of a 54-year old patient with acute demyelinating polyneuropathy during infection by SARS-CoV-2 who progressed clinically to require assisted ventilation. After several weeks of specific symptomatic treatment, the patient had a favorable outcome. In conclusion, despite being a rare complication, we think it is important to consider the possibility of diffuse involvement of the peripheral nervous system in patients with COVID-19 to adjust clinical monitoring and treatment in these cases.

    Search related documents:
    Co phrase search for related documents
    • active infection and lung damage: 1, 2, 3, 4, 5, 6
    • active infection and macrophage activation: 1, 2
    • active infection and macrophage activation syndrome: 1
    • acute demyelinating and macrophage activation: 1
    • acute inflammatory response and lung damage: 1, 2, 3, 4, 5, 6, 7, 8
    • acute inflammatory response and macrophage activation: 1, 2, 3
    • acute inflammatory response and macrophage activation syndrome: 1, 2
    • lopinavir hydroxychloroquine and lung damage: 1, 2, 3, 4, 5
    • lopinavir hydroxychloroquine and macrophage activation: 1, 2
    • lopinavir hydroxychloroquine and macrophage activation syndrome: 1, 2
    • lung damage and macrophage activation: 1, 2, 3, 4, 5
    • lung damage and macrophage activation syndrome: 1